Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Salivary Biomarkers in Crohn's Disease and Ulcerative Colitis: A Scoping Review and Evidence Map.

International journal of molecular sciences·2025

Same author

Investigation of liver diseases using liver Doppler ultrasound in patients with inflammatory bowel diseases.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica·2025

Same author

PREVALENCE OF HELICOBACTER PYLORI INFECTION AMONG GASTROENTEROLOGISTS AND GASTROENDOSCOPISTS IN BRAZIL.

Arquivos de gastroenterologia·2025

Same author

Ultra-Processed Foods, Gut Microbiota, and Inflammatory Bowel Disease: A Critical Review of Emerging Evidence.

Nutrients·2025

Same author

Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety.

BMC gastroenterology·2025

Same author

Expression of MicroRNAs in Adults with Celiac Disease: A Narrative Review.

International journal of molecular sciences·2024

Search research articles

Video Experimental Relacionado

Updated: Sep 10, 2025

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Published on: February 5, 2021

Enfermedades inflamatorias intestinales en Brasil: viaje de los médicos que atienden a los pacientes. ¿Cuál es la

Marcela Maria Silvino Craveiro¹, Lígia Yukie Sassaki², Eduardo Garcia Vilela³

¹Universidade Estadual Paulista, Faculty of Medicine, Department of Surgery and Orthopedics - Botucatu (SP), Brazil.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery

|August 20, 2025

Resumen

Este estudio presenta los perfiles de los médicos que tratan las enfermedades inflamatorias intestinales (EII) en Brasil, destacando los desafíos en el acceso a los medicamentos y las pruebas. Los hallazgos enfatizan la necesidad de mejorar las políticas de salud para apoyar la atención de los pacientes con EII.

Más Videos Relacionados

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

Videos de Experimentos Relacionados

Last Updated: Sep 10, 2025

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Published on: February 5, 2021

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

Área de la Ciencia:

Gastroenterología
Política de salud pública

Sus antecedentes:

Las enfermedades inflamatorias intestinales (EII), incluida la enfermedad de Crohn y la colitis ulcerosa, son cada vez más frecuentes en todo el mundo.
El manejo efectivo de las EII requiere comprender los perfiles médicos y los desafíos del tratamiento.
La política de salud, incluido el acceso a medicamentos y diagnósticos, tiene un impacto significativo en la atención de los pacientes con EII.

Objetivo del estudio:

Para perfilar a los médicos que tratan a pacientes con EII en Brasil.
Analizar los desafíos y la importancia de la atención de la EII.
Identificar los factores que dificultan el diagnóstico y el tratamiento.

Principales métodos:

Estudio transversal utilizando una base de datos preexistente del Grupo Brasileño de Estudio de Enfermedades Inflamatorias del Intestino.
Análisis estadístico descriptivo e inferencial de las características demográficas y prácticas de los médicos.
Evaluación del acceso a los medicamentos, pruebas complementarias y equipos multidisciplinarios.

Principales resultados:

Los perfiles de los médicos incluían especialidad, carga de pacientes y dificultades de acceso a medicamentos, diagnósticos y equipos multidisciplinarios.
El análisis estadístico reveló correlaciones entre el Índice de Desarrollo Humano, el lugar de trabajo, el acceso a la medicación y las referencias especializadas.
Se encontraron asociaciones significativas entre la demografía de los médicos y los desafíos en el acceso a medicamentos y exámenes complementarios.

Conclusiones:

El estudio ha perfilado con éxito a los médicos que tratan a pacientes con EII en Brasil.
Se identificaron factores externos clave que dificultan el diagnóstico y el tratamiento, independientemente de la competencia del médico.
Los hallazgos subrayan la necesidad de mejorar las políticas de salud pública adaptadas al manejo de la EII.